Docetaxel/cisplatin.: A palliative therapy concept in advanced gastric cancer

被引：0
|
作者：
Ridwelski, K [1 ]
Gebauer, T [1 ]
Fahlke, J [1 ]
Kröning, H [1 ]
Kettner, E [1 ]
Lippert, H [1 ]
机构：
[1] Otto Von Guericke Univ, Hosp Surg, Magdeburg, Germany
来源：
3RD INTERNATIONAL GASTRIC CANCER CONGRESS | 1999年
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Between 1/97 to 10/98 43 patients (pts.)- 30 male and 13 female - with advanced or metastatic gastric cancer (median age of 62.4 (39-75) years) were enrolled in our study. The study finished 39 pts. according to protocol. After application from Docetaxel 75 mg/sqm and Cisplatin 75 mg/sqm we saw 4 CR (10,3%), 12 PR (30,8%), 1 MR (2,5%), 10 SD (25,5%) und 12 P (30,8%). The ORR was 17/39 (43.6%). The median survival time was 12.5 months and the median time to progression 5,8 months. These results show, that the combination of Docetaxel and Cisplatin is a high effective polychemotherapy regarding RR and median survival time. The protocoll could also be proofen as a neoadjuvant concept.
引用
收藏
页码：773 / 777
页数：5
相关论文
共 50 条
  • [31] A Randomized Phase 2 Study of Docetaxel and S-1 Versus Docetaxel and Cisplatin in Advanced Gastric Cancer With an Evaluation of SPARC Expression for Personalized Therapy
    Jeung, Hei-Cheul
    Rha, Sun Young
    Im, Chong Kun
    Shin, Sang Joon
    Ahn, Joong Bae
    Yang, Woo Ick
    Roh, Jae Kyung
    Noh, Sung Hoon
    Chung, Hyun Cheol
    CANCER, 2011, 117 (10) : 2050 - 2057
  • [32] A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer
    Kim, Young Saing
    Sym, Sun Jin
    Park, Se Hoon
    Park, Inkeun
    Hong, Junshik
    Ahn, Hee Kyung
    Park, Jinny
    Cho, Eun Kyung
    Lee, Woon Ki
    Chung, Min
    Lee, Jae Hoon
    Shin, Dong Bok
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (01) : 163 - 169
  • [33] A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer
    Young Saing Kim
    Sun Jin Sym
    Se Hoon Park
    Inkeun Park
    Junshik Hong
    Hee Kyung Ahn
    Jinny Park
    Eun Kyung Cho
    Woon Ki Lee
    Min Chung
    Jae Hoon Lee
    Dong Bok Shin
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 163 - 169
  • [34] Docetaxel clearance and cisplatin administration: Implications for toxicity of docetaxel, cisplatin, and fluorouracil (DCF) in gastric cancer
    Power, D. G.
    Wu, N.
    Qin, W.
    Sully, D.
    Cisek, C.
    Randazzo, J.
    Ritch, P. S.
    Jhawer, M. P.
    Kelsen, D. P.
    Shah, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [35] Phase II study of combination therapy with docetaxel, cisplatin, and S-1 (DCS) for advanced gastric cancer: (KDOG 0601)
    Nakayama, N.
    Koizumi, W.
    Sasaki, T.
    Tanabe, S.
    Nishimura, K.
    Higuchi, K.
    Takagi, S.
    Katada, C.
    Azuma, M.
    Saigenji, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [36] Docetaxel and cisplatin in patients with advanced gastric cancer: results of Japanese phase I/II study
    Soh Saitoh
    Yuh Sakata
    Gastric Cancer, 2002, 5 (Suppl 1) : 23 - 26
  • [37] Subsets of patients with advanced gastric cancer responding to second-line chemotherapy with docetaxel - Cisplatin
    Polyzos, Aristides
    Tsavaris, Nikolas
    Kosmas, Christos
    Polyzos, Kostas
    Giannopoulos, Athanasios
    Felekouras, Evangelos
    Nikiteas, Nikolas
    Kouraklis, Gregory
    Griniatsos, John
    Safioleas, Michael
    Stamatakos, Michael
    Pikoulis, Emmanuel
    Papachristodoulou, Antonios
    Gogas, Helen
    ANTICANCER RESEARCH, 2006, 26 (5B) : 3749 - 3753
  • [38] Docetaxel and cisplatin in patients with advanced or recurrent gastric cancer: A multicenter phase I/II study
    Mitachi Y.
    Sakata Y.
    Ohtsu A.
    Hyodo I.
    Katsu K.
    Sairenji M.
    Saitoh S.
    Suwa T.
    Sato T.
    Miyata Y.
    Gastric Cancer, 2002, 5 (3) : 160 - 167
  • [39] DOCETAXEL, CISPLATIN, 5-FLUOROURACIL CHEMOTHERAPY IN YOUNG KOREAN PATIENTS WITH ADVANCED GASTRIC CANCER
    Shim, H.
    Cho, M.
    Park, M.
    ANNALS OF ONCOLOGY, 2009, 20 : 88 - 88
  • [40] Phase I Study of Docetaxel, Cisplatin and S-1 in Patients with Advanced Gastric Cancer
    Hironaka, Shuichi
    Yamazaki, Kentaro
    Taku, Keisei
    Yokota, Tomoya
    Shitara, Kohei
    Kojima, Takashi
    Ueda, Shinya
    Machida, Nozomu
    Muro, Kei
    Boku, Narikazu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (11) : 1014 - 1020
12345